tation results in a sudden increase in the amount of transmitter released by the synapses of the sensory neurons as a result of activity in another neuronal pathway (Fig. 3) . We suggest that these pathways contact the presynaptic terminals of the sensory neurons and regulate their transmitter release. The existence of presynaptic facilitation has been suggested in several synaptic systems on the basis of indirect evidence (5, 10); our data provide direct evidence for its occurrence.
; I. Kupfermann, T. J. Carew, E. R. Kandel, J. Neurophysiol. 37, 996 (1974) . 8 . The connections between sensory and motor neurons were studied by inserting a single microelectrode into a sensory neuron; the electrode was connected to a Wheatstone bridge circuit for intracellular stimulation and recording. A low-resistance, double-barreled electrode was placed into a motor cell, usually gill motor neuron L7 (Fig. IA) . The signals from the motor cell were led to a cathode follower and then to a d-c and a high gain a-c amplifier (Tektronix No. 2A61). To minimize baseline noise, the hand width of the a-c amplifier was set between 0.6 1178 and 60 hertz. Data were tape-recorded and later displayed (Brush recorder No. 440).
9. V. F. Castellucci and E. R. Kandel, Proc. Natl. Acad. Sci. U.S.A. 71, 5004 (1974 have not been recognized accurately by visual inspection. We therefore averaged all the failures encountered in five experiments with a PDP-8 computer. We also averaged the background activity 2 seconds before the occurrence of the triggered presynaptic spikes. In all cases, the averages of the failures and of the background activity were indistinguishable. We observed no time-locked depolarizations, which might have suggested an undisclosed evoked EPSP hidden in the baseline noise (9) . In addition we examined the possibility that the failures occurred because of a conduction block in the terminals of the sensory cells. If this were so, the failures should have. occurred in groups. To determine whether the failures tended to occur in groups, we used the Poisson equation e -m, e-3'%.., and found that the number of successive failures did not exceed that predicted by the Poisson equation. 14. By assuming that the first peak in a histogram was q, we also examined the fit between the observed data in a histogram of EPSP amplitudes and the values predicted by a Poisson distribution. Knowing E, we could derive m. In 31 of 38 regions, the predicted values were not statistically different from the observed values (P > .05). For a given region, three to seven quantal classes were used with a minimum of five predicted responses in each class. The predicted and observed distributions were comared in a chi-square Sensitization of the gill-withdrawal reflex in Aplysia involves a presynaptic facilitation of neurotransmitter output at the monosynaptic connections made by an identified group of 24 sensory neurons innervating the siphon skin and six identified gill motor cells (1) . We have found that facilitation can be simulated by serotonin and that this action may be mediated by adenosine 3',5'-monophosphate (cyclic AMP).
Facilitation associated with short-term sensitization is not affected by prolonged inhibition of protein synthesis (2) . This finding suggested to us that facilitation might result from a small molecule within the presynaptic terminal, perhaps an intracellular second messenger, regulating the mobilization of the transmitter packets from one storage compartment to another. This idea was supported by the finding that strong and prolonged electrical stimulation of the connectives from the head (or other pathways that produce the facilitation) leads to a pro-' longed, synaptically mediated increase in cyclic AMP in the abdominal ganglion (3). This action can be simulated by three biogenic amines: dopamine, octopamine, and serotonin (4). Exposure to one of these substances for 5 minutes increases cyclic AMP in the ganglion. The duration of this increase (up to 45 minutes) resembles that of presynaptic facilitation (and of short-term sensitization) produced by strong facilitating stimuli. This parallel suggested that presynaptic facilitation might be due to octopamine, dopamine, or serotonin and that the amine might mediate its effect on transmitter release by increasing the concentration of cyclic AMP in the presynaptic terminals of the sensory neurons.
To test this possibility, we examined the actions of serotonin, dopamine, and octopamine on the monosynaptic connection between the sensory neurons and the major gill motor neurons (usually cell L7). We found that only serotonin enhanced synaptic transmission (Fig.  IA) . A sensory neuron was first stimulated intracellularly 15 times, once every 10 seconds, to produce synaptic depression (5) . During the next 2.5 minutes, the sensory neuron was not stimulated, and the ganglion was exposed to serotonin (1 × 10-4M or 1 × 10-rM). At the end of the 2.5-minute period of rest, a second series of 15 stimuli was given. Serotonin in concentrations of 10-rM produced facilitation, and the higher concentration (10-4M) produced greater facilitation. A similar result in another system in Aplysin has been described (6) .
We next attempted to block the synaptic facilitation of the excitatory postsynaptic potential (EPSP) with cinansefin (Squibb), which blocks the action of serotonin in the Aplysia heart (7). Cinanserin did not affect the synaptic depression produced by repeated stimulation, but it reversibly blocked the facilitation produced by connective stimulation (Fig. 1B) . Other serotonin antagonists (lysergic acid diethylamide, methysergide and curare) were not effective.
We next asked whether serotonin m!ght act by increasing cyclic AMP. We exposed the ganglion to 2 rffM Nn,O2'-dibutyryl cyclic AMP, and found that it enhanced the evoked EPSP in the motor neurons; this action was specific. Two other excitatory synapses in the ganglion that do not undergo presynaptic facilitation [the one mediated by the right connective onto RI5 (2) and the one made by LI0 on RI5 (5)] were not facilitated by dibutyryl cyclic AMP.
Because the site of action of cyclic AMP is primarily intracellular, we injected cyclic AMP into the cell body of the sensory neuron (Fig. 2, A and B) by an experimental procedure similar to the above (Fig. IA) .
Injection of cyclic AMP did not alter the amplitude or the duration of the spike in the cell body of the sensory neuron, but it enhanced the synaptic potential produced by each action potential. We compared these results with four types of controls. One group (N = 5) received 2.5 minutes of rest. A second group (N = 6) received a hyperpolarizing current pulse comparable to that used to inject cyclic AMP but from an electrode filled with 3M potassium citrate. Into a third group of cells (N = 4) we injected guanosine Y,5'-monophosphate (cyclic GMP, 1.5M), which has been implicated in effects opposite to those of cyclic AMP in some hormonal systems (8) . in the fourth control group (N = 3) we injected 5'-AMP, the breakdown product of cyclic AMP ( During the initial EPSP depression, the control and experimental curves overlapped completely. But after treatment with serotonin, both experimental curves were significantly higher than the control curve (P < .016 for 2 x 10-'M and P < .028 for 2 x 10-~M; one-tailed Mann-Whitney U test). To determine the statistical differences between the experimental and the control curves, the amplitudes of the responses to each of the 15 stimuli of a run were summed to obtain a single score. (B) Time course of synaptic depression and facilitation in the presence and absence Of cinanserin. Complex EPSP's were evoked by stimulating the siphon nerve (ISI, 10 seconds). Average EPSP's are plotted as percentages of initial EPSP amplitude. After 15 control stimuli had produced synaptic depression, a facilitating stimulus (6 hertz for 10 seconds) was applied to the left connective (LC) and 15 additional test stimuli were delivered; responses to these stimuli were facilitated compared to the preceding responses. After 13 minutes of rest, the ganglion was perfused with 3 x 10-'M cinanserin (dark bar); 2 minutes later, the experimental procedure was repeated. In the presence of cinanserin, synaptie depression was obtained as before, but stimulating the connective did not produce synaptic facilitation (N = 7). A final control run (N = 4), which was carried out 30 minutes after cinanserin was washed out of the chamber, produced facilitation.
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mental group were significantly higher than those of either the first (rest) control group (P < .002) or the three other control groups (group 2, P < .001; group 3, P < .014; group 4, P < .012). Moreover, none of the last three controls produced significant facilitation when compared to the first (rest) control. Thus, on the basis of these and earlier published data (1) we propose a specific and, it is to be hoped, testable model of the mechanisms underlying habituation and sensitization (Fig. 3) . In the sensory neurons, the repeated activity that accompanies habituation reduces the release of transmitters, perhaps because of either (i) a progressive failure to mobilize transmitter from a storage compartment to one from which it can be released or (ii) a decrease in the probability of release.
Sensitization restores transmission as a result of the activation of one or more serotonergic neurons. These neurons enhance transmitter release by acting on the terminals of sensory neurons to increase their intracellular concentrations'of cyclic AMP (9) . In a second group, a hyperpolarizing current pulse, comparable to that used to inject cyclic AMP, was injected into the sensory neuron but the pulses were applied through an electrode filled with 3M potassium citrate (open triangles) (N = 6). In a third group, cyclic GMP (I.5M) was injected intracellularly (open circles) (N = 4). In a fourth group, 5'-AMP (closed triangles) (N = 3) was injected. The five curves generated during the initial EPSP depression produced by the first 15 stimuli overlap completely. But after injection of cyclic AMP the experimental group was significantly higher than either the first control group (P < .002, one-tailed Mann-Whitney U test) or the three other control groups (for potassium citrate, P < .001; for cyclic GMP, P < .014; for Y-AMP, P < .012). cyclic AMP in turn enhances mobilization or the probability of release either (i) by increasing the free Ca 2+ in the terminals or (ii) by acting on the Ca 2+ conductance of the external membrane of the terminals or on subcellular organelles. Our data provide direct evidence that serotonin and cyclic AMP can facilitate synaptic transmission between the sensory and motor neurons mediating the gill-withdrawal reflex (10) . Cyclic AMP may, thereforr, have a role in the shortterm memory produced by behavioral sensitization. By extension, cyclic AMP may also have a role in the prolonged in, crease in responsiveness that accompanies behavioral arousal (11). However, the model (Fig. 3) is still speculative since the data we present for it are indirect and therefore not compelling. In particular, we have not yet identified the specific cell or cell group that mediates presynaptic facilitation and shown it to be serotonergic. Nor have we shown that the action of presumptive serotonergic cells actually increases endogenous cyclic AMP in the sensory neurons.
M. BRUNELLI V. CASTELLUCCI E. R. KANDEL
Division of Neurobiology and Behavior, College of Physicians and Surgeons of Columbia University, New York 10032
It.
tization of the biting response in Aplysia after food is presented is produced by serotonergic neurons that act on the feeding muscle and is apparently also mediated by cyclic AMP (see also K. Weiss, J. Cohen, I. Kupfermann, Brain Res. 99, 381 (1.975). In Aplysia, as in some other invertebrates, serotonin sometimes produces actions that are mediated by norepinephrine in vertebrates, perhaps because these animals lack the enzyme dopamine-/3-hydroxylase and cannot synthesize norepinephrine. An example is the innervation of the heart ofAplysia, where inhibition is mediated by acetylcholine (as it is in vertebrates), but where excitation is mediated by serotonin (rather than norepinephrine, as it is in vertebrates) (7). In both mollusks and vertebrates, the action of the biogenic amine may be mediated by cyclic AMP. In Aplysia, as in vertebrates, sensitization seems to be a component of behavioral arousal [P. M. Groves and R. F. Thompson, Psychol.
12.
Rev. 77, 419 (1970); T. J. Carew, V. F. Castellucci, E. R. Kandel The clinical management of ethanol withdrawal has to take into account both acute and chronic aspects of ethanol intake. During the early stages of the withdrawal period, a subject displays signs of intoxication similar to those observed during the first drinking episode. As detoxification proceeds and the blood ethanol concentrations decline to approximately 100 mg/dl, a gradual transition develops from depression to hyperexcitability. With the total elimination of blood ethanol, a series of neurological signs and reactions emerge which include general agitation, tremors, convulsions, hallucinations, and delirium tremens (1) . In addition, a number of side effects resulting from long-term intoxication with heavy doses of ethanol are evident. These may include malnutrition, weight loss, a lessened resistance to infection, hepatitis, cirrhosis of the liver, various vitamin deficiencies, peripheral neuropathy, and general neurological, psychiatric, and clinical deterioration (I). Thus, an ethanol withdrawal syndrome can be a serious medical problem and may be fatal if not properly managed. Therefore, the primary aim of treatment is to reduce the neuromuscular and autonomic hyperactivity, thereby preventing exhaustion so that necessary clinical management and treatment can proceed (1).
Empirically, any drug that will sup-
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press nervous excitability may ameliorate the severity of the withdrawal reaction. To date, a variety of compounds that are either structurally or pharmacologically similar to ethanol have been effective in treatment (2) . Among these are aliphatic alcohols and their corresponding aldehydes, paraldehyde, chloral hydrate, barbiturates, phenothiazines, and benzodiazepines (2) . However, the optimal drug is not only efficacious in controlling the withdrawal syndrome, but is devoid of major side effects. Of the drugs just listed, some are either more toxic than ethanol or have severe side effects, including their ability to induce dependence (2) . The availability of a number of animal models of ethanol dependence (3) now allows the testing of a variety of potential therapeutic agents for their ability to suppress the signs and responses of the ethanol withdrawal syndrome. Using our model of ethanol dependence in the rat (4), we screened a number of compounds listed above and found some effective. In addition, 1,3-butanediol (BD), a compound of low toxicity (5-7) suppresses a variety of signs and responses in rats characteristic of the ethanol withdrawal syndrome.
Male Sprague?Dawley rats (200 to 300 g) were rendered ethanol dependent by intubation of a 20 percent solution of ethanol at a dose of 9 to 15 g/kg da'ily in up to six fractions over a 4-day period (4). Since we used the maximum tolerable doses for the induction of ethanol dependence, about one-fifth of the animals usually died as a result of overdosage. On the day of withdrawal, the animals were observed at hourly intervals, initially for the disappearance of ethanol intoxication during the prodromal detoxication phase and then for the onset of a withdrawal syndrome during the ethanol dependence phase. With the onset of signs of the ethanol withdrawal syndrome, blood samples were taken also at hourly intervals from the tail vein; this continued until the complete clearance of ethanol from the blood. Blood ethanol levels were determined by means of an automated adaptation (8) of a gas chromatographic method of Roach and Creaven (9) . A t this point, the animals were
